The Clinical Centre of Niš is a medical centre located in Niš, Serbia. It serves as the main medical centre for both Niš and Southern and Southeastern Serbia.

There are 1,525 (2017) beds in Clinical Center Nis.

During the past decade, Clinical Center Nis conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 36 clinical trials were completed, i.e. on average, 46.8% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 25 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Center Nis" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Pfizer" with 7 trials sponsored, "Takeda" with 7 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored and "Shire" with 5 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Center Nis" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "3ARH" with 1 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Center Nis" are "Crohn's Disease" (7 trials), "Multiple Sclerosis" (7 trials), "Breast Cancer" (5 trials), "Ulcerative Colitis" (4 trials) and "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials). Many other conditions were trialed in "Clinical Center Nis" in a lesser frequency.

Most popular intervention types in "Clinical Center Nis" are "Drug" (87 trials), "Other" (14 trials), "Biological" (9 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Carboplatin" (8 trials), "Gemcitabine" (4 trials), "Ocrelizumab" (4 trials) and "Ontamalimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Center Nis" are 95 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Center Nis". undefined are not yet recruiting, 24 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 48 completed trials in Clinical Center Nis, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Center Nis, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".

Clinical Center Nis has several departments that took part in Clinical trials: "Clinical Centre Nis, Clinic for mental health protection" - 3 trials, "Clinic of Haematology Cc Nis" - 2 trials, "Children's Clinic of Internal Medicine" - 2 trials, "Klinički Centar Niš, Klinika za onkologiju" - 2 trials, "Clinical Center Nis, Clinic for Psychiatry" - 2 trials, "Clinical Centre of Nis, Clinic for Gastroenterology and Hepatology" - 2 trials